White label ELPA - ClinicalTrials.eu

Study on Oxygen Therapy and Drug Combination for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Recruiting

3 1 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
Study on Atorvastatin for Preventing Episodic Migraine in Adults

Recruiting

2 1 1 1
Investigated diseases:
- Migraine
Investigated drugs:
- Atorvastatin
- Placebo
Safety Study of NB-4746 with Riluzole and Placebo in Adults with Amyotrophic Lateral Sclerosis (ALS)

Recruiting

1 1 1
Investigated drugs:
- Riluzole
Study on the Effects of OATD-01 for Patients with Active Pulmonary Sarcoidosis

Recruiting

2 1
Investigated diseases:
- Pulmonary sarcoidosis
Investigated drugs:
- 5-(4-((2S,5S)-5-(4-Chlorobenzyl)-2-Methylmorpholino)Piperidin-1-Yl)-1H- 1,2,4-Triazol-3-Amine
Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Recruiting

3 1 1 1
Investigated diseases:
- Hormone-dependent prostate cancer
Investigated drugs:
- Apalutamide
- Docetaxel
AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

Recruiting

2 1 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:
- AMG 732
Zongertinib with cisplatin or carboplatin and pemetrexed, with or without pembrolizumab, for patients with locally advanced or metastatic non-squamous non-small cell lung cancer with HER2 mutations

Recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Semaglutide
+1
AUR200 for Patients with Generalized Myasthenia Gravis

Recruiting

1 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- AUR200
- Sodium Chloride
GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

Recruiting

3 1

+4

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies